| Date Posted |
Subject |
| Dec. 30, 2003 |
Incidence of Acute Hepatitis B - United States, 1990-2002 (CDC/MMWR. Jan. 2) |
| Dec. 29, 2003 |
Letter from CA Dept of Health Services (Dec. 23) announcing elimination of the State DDR (PDF) |
| Dec. 23, 2003 |
First U.S. case of mad cow disease (CNN); U.S. Mad Cow Link Raised in Creutzfeldt-Jakob Cases (Reuters, Dec. 26) |
| Dec. 23, 2003 |
'Sticky blood' gives malaria clue (BBC); Original article (PNAS Online) |
| Dec. 18, 2003 |
Seftel, MD et al. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood, Jan 1, 2004 |
| Dec. 18, 2003 |
Immunizations strongly recommended for health-Care personnel (HCP) (CDC/MMWR, Dec. 19) |
| Dec. 17, 2003 |
Blood donor 'may have passed CJD' - A UK man who died from CJD may be the first in the world to have caught the illness from a blood transfusion (BBC News, Dec. 17); European Union seeks report on 'mad cow' blood transfusion (Daily Times, Pakistan - Dec. 29) |
| Dec. 17, 2003 |
Blajchman, MA, Goldman, M and Baeza, F, Improving the bacteriological safety of platelet transfusions, Transfusion Medicine Reviews, 18(1):11-24, Jan. 2004. |
| Dec. 17, 2003 |
Glenn Ramsey, Managing recalls and withdrawals of blood components, Transfusion Medicine Reviews, 18(1):36-45, Jan. 2004. |
| Dec. 17, 2003 |
Guidance for Industry and FDA Staff: Class II Special Controls Guidance Document: Human Dura Mater (FDA/CDRH) |
| Dec. 16, 2003 |
Physics of Platelet Swirling- Slides from PowerPoint presentation on CD-ROM sent to AABB Institutional Members (AABB) |
| Dec. 12, 2003 |
Fludarabine Causes Transfusion-Associated GVHD in a Patient Without Underlying Malignant Disease (Doctor's Guide; Leitman Sf et al. Transfusion, Dec. 2003). See related eNF issue |
| Dec. 11, 2003 |
Antia R et al. The role of evolution in the emergence of infectious diseases (requires registration) (Nature Online) |
| Dec. 10, 2003 |
Blood Donations Benefit Charities (USC Chronicle) |
| Dec. 10, 2003 |
ASH: Treat Anemia Early, Even if Mild, During Blood Cancer Therapy (Doctor's Guide) |
| Dec. 10, 2003 |
Bacterial Contamination of Blood Components: Risks, Strategies, and Regulation- Joint ASH and AABB Educational Session in Transfusion Medicine. Hillyer et al. (Hematology) |
| Dec. 9, 2003 |
Health records in England put on Internet - Patients will be able to access their records via the Internet (BBC) |
| Dec. 9, 2003 |
Breakthroughs Lead To Better Understanding In Prevention Of Transfusion-transmitted Infection - (ASH/Science Daily) |
| Dec. 8, 2003 |
American Red Cross Considers Testing Donors for Chagas in the future (AJC) |
| Dec. 8, 2003 |
Bar Codes on Drugs Aim to Reduce Errors - Implications for Blood (AJC) InteliHealth(Dec. 9) |
| Dec. 4, 2003 |
Reveal™ Rapid HIV-1 Antibody Test: Summary of Safety and Effectiveness (FDA/CBER) |
| Dec. 4, 2003 |
Interleukin-10 gene variant protects against acute GVH after bone marrow transplant (Intelihealth); NEJM article |
| Dec. 4, 2003 |
Update: Creutzfeldt-Jakob Disease Associated with Cadaveric Dura Mater Grafts - Japan, 1979-2003 (CDC/MMWR) |
| Dec. 3, 2003 |
Women's plasma in surgery ban- blood product can threaten life of patients (Guardian UK) |
| Nov. 26, 2003 |
Squeezing out platelet contamination (CAP Today) |
| Nov. 23, 2003 |
Physicians Urged to Treat Anaemia in Patients with Advanced Lung Cancer (Doctor's Guide) |
| Nov. 20, 2003 |
Clarification Regarding A Response to "Ask the FDA" session at the 2003 AABB meeting in San Diego (AABB) See also discussion in e-Network forum (Dec. 9) |
| Nov. 19, 2003 |
Hepatitis A Outbreak in Western Pennsylvania Prompts Broadened Donor Deferrals by local blood centers (ABC); Epidemiological Investigation (MMWR, Nov. 28; corrected) |
| Nov. 19, 2003 |
First Prion Reduction Product Presented at the European Plasma Fractionation Association Conference |
| Nov. 18, 2003 |
Rare Infection (Chagas Disease) Threatens to Spread in Blood Supply (NY Times, Nov. 18) (may require registration); CDC Fact Sheet (Nov. 19)
|
| Nov. 17, 2003 |
AABB Education/Training Materials (Transfusion Considerations for ABO Incompatible Hematopoietic Progenitor Cell (HPC); Serologic Evaluation of Patients with Warm-Reactive Autoantibodies; Donor Services Training; Informed Consent for Blood Transfusion; Primer of Blood Administration) - available for download (AABB Members only) |
| Nov. 17, 2003 |
New Investigational Vaccine to Prevent Hepatitis C Tested for First Time in Humans by researchers at St Louis University |
| Nov. 13, 2003 |
New test method helps reduce blood safety fears (China View) |
| Nov. 12, 2003 |
Increased Risk of Blood Transfusion with Serotonergic Antidepressant Use in Older Patients Undergoing Orthopaedic Surgery - Review (Doctor's Guide) |
| Nov. 10, 2003 |
Blood Bank Information Systems Survey (CAP Today, Oct 2003; PDF) (Nov 11)
|
| Nov. 10, 2003 |
Anaemia and red blood cell transfusion in the critically ill patient. McLellan, SA et al. Blood Reviews. Dec. 2003 |
| Nov. 7, 2003 |
FDA Updates Biological Product Deviation Reporting (AABB PulsePoints) |
| Nov. 7, 2003 |
Muscle 'could pose tiny CJD risk' (BBC); Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt-Jakob Disease (NEJM)
|
| Nov. 6, 2003 |
Probable Transfusion-Transmitted Malaria - Houston, Texas, 2003 (CDC/MMWR, Nov. 6) |
| Oct. 31, 2003 |
Update on Particulate Matter in Blood Bags (FDA/CBER) |
| Oct. 27, 2003 |
Informed consent can reduce malpractice claims (accreditinfo.com) |
| Oct. 27, 2003 |
Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma; CORRECTION (FDA/CBER - Federal Register, Oct 27)
|
| Oct. 25, 2003 |
Hemochromatosis subjects as allogeneic blood donors: a prospective study. Leitman, S et al. in Transfusion Nov. 2003 43(11). |
| Oct. 25, 2003 |
Weakening or loss of antibody reactivity after prewarm technique Leger, R.M. & Garratty, G. in Transfusion Nov. 2003 43(11). |
| Oct. 24, 2003 |
Chemical Listed Effective October 24, 2003 as Known to the State of CA to Cause Reproductive Toxicity: Di(2-ethylhexyl)phthalate (DEHP) (OEHHA, Oct 24); Related notification on DEHP by FDA, July 2002) |
| Oct. 22, 2003 |
Cutaneous Leishmaniasis in U.S. Military Personnel - Southwest/Central Asia, 2002-2003 (CDC/MMWR)
|
| Oct. 22, 2003 |
AABB Celebrates 45th Anniversary of Accreditation Program (AABB) |
| Oct. 15, 2003 |
Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000 (Canadian Medical Association Journal, Oct. 15) |
| Oct. 15, 2003 |
According to the College of American Pathologists, Medicare should base outpatient prospective payment rates for blood and blood products on reasonable costs or outside hospital acquisition cost data. CAP has submitted its opinion in written comments to the Centers for Medicare and Medicaid Services. (CAP) |
| Oct. 15, 2003 |
Assistance requested in investigating possible associations of ABO with vonWillebrand factor |
| Oct. 10, 2003 |
AABB PulsePoints No. 613: Association Bulletin #03-14: Deferral for Risk of Leishmaniasis Exposure
|
| Oct. 9, 2003 |
Circular of Information for the Use of Cellular Therapy Products- Click on link to COI (PDF) in BB column on right (ISCT, Oct. 9) |
| Oct. 7, 2003 |
The Military will Temporarily Ban Blood Donations from Soldiers and Others in Iraq due to risk of Leishmaniasis The link here is a pdf file containing related memos and information sheets from ASBPO (Oct. 8); AABB recommends similar deferral (Association Bulletin 03-14) for all blood collection agencies (AABB PulsePoints, Oct. 10) |
| Oct. 1, 2003 |
Association Bulletin #03-13: Summary of Information Regarding Intranasal Flu Vaccine (FluMistTM) and Recommendations on Donor Acceptability (AABB PulsePoints) |
| Oct. 1, 2003 |
Association Bulletin #03-12: Further Guidance for Facilitating Implementation Methods to Detect Bacterial Contamination of Platelet Components (AABB PulsePoints) |
| Sept 28, 2003 |
Confidence in Blood System Restored Five Years After Creation of Canadian Blood Services (Canadian Blood Services) |
| Sept 28, 2003 |
American National Red Cross- Consent Decree Correspondence (FDA/CBER) |
| Sept 27, 2003 |
Biological Product Shortages (FDA/CBER) |
| Sept 25, 2003 |
Factors affecting the risk of blood bank specimen hemolysis - Tanabe P. et al. Acad Emerg Med.,Aug 10, 2003 |
| Sept 25, 2003 |
Transmission of Hepatitis B and C Viruses in Outpatient Settings - New York, Oklahoma, and Nebraska, 2000-2002 (CDC/MMWR) |
| Sept 22, 2003 |
Final Guidance for Industry: Notifying FDA of Fatalities Related to Blood Collection or Transfusion (FDA/CBER) |
| Sept 19, 2003 |
"Forgotten" Malaria Still Kills Millions (InteliHealth, Sept. 19) |
| Sept 19, 2003 |
California State DDR Requirement eliminated with passage of SB 1081 (PDF) |
| Sept 17, 2003 |
Current Blood Supplies Sufficient in Areas Facing Arrival of Hurricane Isabel (AABB)
|
| Sept 17, 2003 |
Impact of Severe Weather Conditions on Biological Products (FDA/CBER) |
| Sept 16, 2003 |
Revised Recommendations for the Assessment of Donor Suitability and Blood Product Safety in Cases of Suspected Severe Acute Respiratory Syndrome (SARS) or Exposure to SARS (FDA/CBER) |
| Sept 15, 2003 |
Riding up and down on the Universal Leukocyte Reduction (ULR) seesaw (CAP Today) |
| Sept 12, 2003 |
Association Bulletin #03-11: Update on WNV Related Activities and Recommendations (AABB) |
| Sept 5, 2003 |
Shared razor may have spread HIV (BBC) |
| Sept 5, 2003 |
Product Approval Information - Licensing Action: Immune Globulin Intravenous (Human) - Gamunex (Bayer) (FDA/CBER) |
| Sept 4, 2003 |
Substantially Equivalent 510(k) Device Information: Magellan Autologous Platelet Separation System - Medtronic (FDA/CBER) |
| Sept 4, 2003 |
Baxter and Cerus Halt Red Blood Cell Clinical Trials for Investigational Pathogen Inactivation System |
| Sept 3, 2003 |
California Proposes to End Laboratory Oversight (CAP Statline) |
| Aug 29, 2003 |
Options for Arm Preparation (FDA/CBER) |
| Aug 28, 2003 |
Recommendations for Evaluation of Possible Cases of Transfusion-Transmitted WNV Infection Following Implementation of Investigational Nucleic Acid Testing (AABB Association Bulletin #03-09) AABB Membership required |
| Aug 28, 2003 |
Blood Products Advisory Committee September 18, 2003 Meeting |
| Aug 18, 2003 |
Patient safety and blood transfusion: new solutions. Dzik WH, Corwin H, Goodnough LT, Higgins M, Kaplan H, Murphy M, Ness P, Shulman IA, Yomtovian R. Transfus Med Rev. July 2003 (Abstract) |
| Aug 18, 2003 |
Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia (Bradai, M et al., Blood, Aug. 15) |
| Aug 17, 2003 |
Chill out - a new idea on platelet storage (CAP Today, Aug. 2003); The clearance mechanism of chilled blood platelets (This article, published in Cell this past January (Hoffmeister KM, et al. 2003;112:87-97) and posted here, has been REACTIVATED in response to renewed interest in cold storage of platelets |
| Aug 15, 2003 |
New Computer Virus - Security Response ("W32.Blaster.Worm") |
| Aug 13, 2003 |
Clot-buster coating for blood cells (BBC News) |
| Aug 11, 2003 |
Manual of Standard Operating Procedures and Policies - Regulatory: License Applications - Complete Review and Issuance of Action Letters (FDA/CBER) |
| Aug 9, 2003 |
The clearance mechanism of chilled blood platelets. Hoffmeister at al, Cell. 2003 Jan 10;112(1). |
| Aug 7, 2003 |
Electronic Human Cell and Tissue Establishment Registration (eHCTERS) (FDA/CBER) |
| Aug 6, 2003 |
Current list of vaccines using bovine-derived materials from countries on the USDA's BSE list or from unknown countries |
| July 31, 2003 |
BCSH Guidelines for the Use of Platelet Transfusions (Brit J Haemat 2003; 122:10 (PDF) |
| July 30, 2003 |
Proposed Rule: Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma (FDA, HHS: Federal Register) |
| July 26, 2003 |
WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. (Blumberg, et al. Transfusion, July 2003) |
| July 26, 2003 |
WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. (Vamvakas EC, Transfusion, July 2003) |
| July 26, 2003 |
New (Albumin-free) Recombinant Antihemophilic Factor Licensed (Baxter) - FDA Talk Paper, letter of approval (July 26) Licensing Action (Aug. 8) |
| July 22, 2003 |
Substantially Equivalent 510(k) Device Information - Greiner Bio-One GmbH Vacuette EDTA K2 Tube (FDA, July 22) |
| July 15, 2003 |
Researchers find mechanism that may determine early blood cell fate (U. of Wisconsin, July 14) |
| July 7, 2003 |
Guidance for Industry: Streamlining the Donor Interview Process - Recommendations for Self-Administered Questionnaires (FDA/CBER, July 7) |
| July 1, 2003 |
Global Screening for Human Viral Pathogens (Anderson NG et al, CDC/EID - July 2003) |
| June 25, 2003 |
Recommended Guidance for Reporting West Nile Viremic Blood Donors (AABB Association Bulletin #03-08) |
| June 12, 2003 |
Blood Frequently Asked Questions (FAQs): 'Is it true that individuals diagnosed with hemochromatosis can now donate?' (FDA/CBER) |
| June 11, 2003 |
Licensed / Approved HIV, HTLV and Hepatitis Tests (FDA/CBER, list updated June 9) |
| May 15, 2003 |
Audit of Transfusion Procedures in 660 Hospitals - A CAP Q-Probes Study of Patient Identification and Vital Sign Monitoring Frequencies in 16,494 Transfusions (Novis DA et al, Arch Path Lab Med, May 2003) May 15 |
| May 14, 2003 |
IOM : Investigations Operations Manual -primary guidance document for FDA field personnel performing inspections and special investigations (FDA/ORA) |
| May 14, 2003 |
CAP Q-Probes study of 8941 type and screen tests in 108 institutions (CAP) |
| May 9, 2003 |
Seminar preps health workers in Canada for West Nile - Government-funded project tracks species that pose risk of spreading virus to human beings: Mosquito identification (National Post, May 9) |
| May 7, 2003 |
High rate of medical errors (OneNews/NZ, May 8) |
| May 7, 2003 |
Risks associated with transfusion of cellular blood components in Canada (Kleinman S et al, Transfus Med Rev Apr 2003) |
| May 3, 2003 |
CAP to Testify on Universal Leukoreduction (CAP Statline) |
| May 2, 2003 |
West Nile Virus Newsletter for Clinicians and Hospital Medical Staff |
| Apr. 20, 2003 |
Allergic Transfusion Reactions: An Evaluation of 273 Consecutive Reactions (ARPA)
|
| Apr. 15, 2003 |
CAP Today (April, 2003): Putting some teeth into anti-HCV testing |
| Apr. 8, 2003 |
FDA/CBER: Blood Establishment Registration and Product Listing (BER): Instructions for Completing the Electronic Blood Establishment Registration and Product Listing Form |
| Apr. 7, 2003 |
Another list of medications affecting donor eligibility (Hema-Quebec- updated May 2, 2005) |
| Apr. 4, 2003 |
AABB Disaster Operations Handbook now ONLINE (also on CBBS Useful Links page) |
| Apr. 3, 2003 |
CDC/MMWR: Hepatitis C Virus Transmission from an Antibody-Negative Organ and Tissue Donor |
| Apr. 3, 2003 |
FDA/CBER: Guidance for Industry: Final Guidance - Xenotransplantation Products for Humans (PDF) |
| Mar. 15, 2003 |
Efficacy of albumin in critically ill patients - BMJ Editorial cites recent US meta-analysis contradicting earlier Cochrane review |
| Mar. 12, 2003 |
Some regional blood centers may implement donor testing for West Nile Virus |
| Mar. 11, 2003 |
FDA/CBER: COUNTERFEIT PRODUCT ALERT - Counterfeiting of Procrit (Amgen, Inc / Ortho Biotech Products, LP); How to identify (Ortho Biotech letter) ; ADDENDUM June 12: Crooks caught by FDA in Miami (InteliHealth, June 12) |
| Mar. 5, 2003 |
FDA/CBER: FDA Current Thinking on Irradiating and/or Freezing Blood Components Collected and Stored in Anticoagulant/Preservative Solutions Not Specifically Approved for Such Use |
| Mar. 3, 2003 |
National Blood Systems Urged to Improve Quality and Access (PAHO Conference on Safe Blood) |
| Feb. 14, 2003 |
CDC/MMWR: Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus |
| Jan. 23, 2003 |
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products - (Nichols WG et al.) Blood, Jan 16, 2003 |
| Jan. 20, 2003 |
Commentary in Lancet, Jan 11 - 'Transfusion medicine: looking to the future' by Goodnough LT, Shander A, Brecher ME |
| Jan. 18, 2003 |
A landmark publication on the body's response to chilled platelets - the bad and the good |
| Jan. 14, 2003 |
Food and Drug Administration (FDA) imposes donor deferral regarding the use of AVODART (dutasteride) |
| Jan. 10, 2003 |
FDA/CBER: Electronic Biological Product Deviation Reporting (eBPDR) - Latest System Changes |
| Jan. 6, 2003 |
FDA/CBER: Blood Establishment Registration and Product Listing (BER) - Instructions for Completing the Electronic Blood Establishment Registration and Product Listing Form (Jan. 6) |
| Jan. 2, 2003 |
MMWR Jan 3: Blood Safety Monitoring Among Persons with Bleeding Disorders - United States, May 1998--June 2002 (Jan. 2)
|
